TEVA Gráfico de velas - StockScan
Battered Teva Pharmaceutical Industries Ltd (ADR) Stock Still Is Toxic
Teva Pharmaceutical Industries - Recent News & Activity
Possible criminal probe undermines recovery in opioid stocks since global legal settlement announced - MarketWatch
Teva Pharmaceutical Is Bottoming: Here's My Strategy - RealMoney
Teva stock drops 10% as generics turnaround looks uncertain - MarketWatch
Teva: Vigodman Steps Down, Peterburg Hired as Interim CEO
Teva Pharmaceutical to Cut 14,000 Jobs - WSJ
What To Do After TEVA Stock Falls Below $10 Again (NYSE:TEVA) | Seeking Alpha
Teva stock drops 10% as generics turnaround looks uncertain - MarketWatch
TEVA | Teva Pharmaceutical Industries Ltd. ADR Stock Overview (U.S.: NYSE) | Barron's
Teva shares rise as company offers reassurance on former flagship drug Copaxone - MarketWatch
Teva Stock Is Falling as an Analyst Says It Needs 'Numerous Litigation Wins' | Barron's
Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Announces Abstracts at the ACAAI Annual Scientific Meeting
Teva Stock Has Crumbled, and Chairman Sol Barer Is Buying Up Shares | Barron's
Teva Pharmaceutical Is Bottoming: Here's My Strategy - RealMoney
Teva shares surge on corporate shake-up - MarketWatch
TEVA - Stock Quotes for TEVA Ent Holdg, NYSE: TEVA Stock Options Chain, Prices and News - Webull
Shares of generic drugmakers rise on hope that legal issues are nearing an end - MarketWatch
What To Do After TEVA Stock Falls Below $10 Again (NYSE:TEVA) | Seeking Alpha
Israel stocks rise, led by Teva, ICL - MarketWatch
Don't just brace for another stock-market nosedive — welcome it - MarketWatch
Teva Pharmaceutical Is Bottoming: Here's My Strategy - RealMoney
How the price action of Teva Pharmaceutical (TEVA) is used to our Advantage - MarketWatch
Teva to acquire Mexico's Rimsa for $2.3 billion - MarketWatch
Teva: This One Is Difficult (NYSE:TEVA) | Seeking Alpha
Teva Pharmaceutical Stock Could Double | Barron's
Investors wary of Teva-Mylan merger - MarketWatch
